Antonio Núñez-Roldán
Research Subjects
Antonio Núñez-Roldán has a total of 464 co-authors. Here are the top co-authors by number of shared publications:
- Isabel Aguilera
Servicio de Inmunología, Hospital Universitario Virgen del Rocío, Sevilla, Spain
26 shared publications I. Wichmann
Department of Immunology, Virgen del Rocio University Hospital, Seville, Spain
13 shared publicationsIngeborg Wichmann
Servicio de Inmunología, Instituto de Biomedicina de Sevilla (IBIS), Hospitale Universitario Virgen del Rocío/CSIC/Universidad de Sevilla. Sevilla, Spain
13 shared publications- Javier Martin
Institute of Parasitology and Biomedicine López-Neyra, CSIC, Granada, Spain
9 shared publications - Manuel Romero-Gómez
UCM Digestive Diseases, Virgen del Rocio University Hospital, SeLiver Group, Institute of Biomedicine of Seville, Ciberehd, Department of Medicine, University of Seville, Seville, Spain
9 shared publications Belén Torres
Hospital Universitario Virgen del Rocío
8 shared publications
Latest Publications
- Open Access
- 13 March 2018
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 1-12
Identification of the cellular components involved in de novo immune hepatitis: a quantitative immunohistochemical analysis
Diagnosis of de novo immune hepatitis (dnIH) after liver transplantation relies on biopsy findings, with an abundance of plasma cells (PCs) in the inflammatory infiltrates a hallmark of the disease. Very little is known about what other types of immune cells exist in the infiltrates mainly located in the portal areas of the liver tissue. We analyzed the composition of T cells, B cells, PCs, and macrophages in the liver biopsies of 12 patients with dnIH, 9 of them obtained at the time of diagnosis. For comparison, biopsies from 9 patients with chronic rejection (CR) were included in the study. The results were analyzed by a computer-assisted stereology quantification method. The major components of the infiltrates in the portal areas were CD3+ T lymphocytes in both groups, with 36.6% in the dnIH group versus 49.4% in the CR group. CD20+ B lymphocytes represented 14.9% in the dnIH group and 29.1% in the CR group. Macrophage levels were very similar in the dnIH and CR group (19.7% versus 16.8%, respectively). PCs were much less represented in CR biopsies than those from the dnIH group (mean value of 4.7% versus 28.8%). In conclusion, the determination of a characteristic cellular profile could be an important tool for a more reliable diagnosis of dnIH, in support of the histological evaluation made by the pathologist, which in most cases is challenging. Recognition of this condition is crucial because it leads to graft failure if left untreated.
- 13 March 2018
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 16 (1) , 1-12
Open AccessIdentification of the cellular components involved in de novo immune hepatitis: a quantitative immunohistochemical analysis
Diagnosis of de novo immune hepatitis (dnIH) after liver transplantation relies on biopsy findings, with an abundance of plasma cells (PCs) in the inflammatory infiltrates a hallmark of the disease. Very little is known about what other types of immune cells exist in the infiltrates mainly located in the portal areas of the liver tissue. We analyzed the composition of T cells, B cells, PCs, and macrophages in the liver biopsies of 12 patients with dnIH, 9 of them obtained at the time of diagnosis. For comparison, biopsies from 9 patients with chronic rejection (CR) were included in the study. The results were analyzed by a computer-assisted stereology quantification method. The major components of the infiltrates in the portal areas were CD3+ T lymphocytes in both groups, with 36.6% in the dnIH group versus 49.4% in the CR group. CD20+ B lymphocytes represented 14.9% in the dnIH group and 29.1% in the CR group. Macrophage levels were very similar in the dnIH and CR group (19.7% versus 16.8%, respectively). PCs were much less represented in CR biopsies than those from the dnIH group (mean value of 4.7% versus 28.8%). In conclusion, the determination of a characteristic cellular profile could be an important tool for a more reliable diagnosis of dnIH, in support of the histological evaluation made by the pathologist, which in most cases is challenging. Recognition of this condition is crucial because it leads to graft failure if left untreated.
- 1 February 2018
- Published by Elsevier in Transplant Immunology
- Vol. 46, 36-41
De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation
- 1 February 2018
- Published by Elsevier in Transplant Immunology
- Vol. 46, 36-41
De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation
- Open Access
- 1 September 2014
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 20 (9) , 1356-1362
Mismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation
- 1 September 2014
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 20 (9) , 1356-1362
Open AccessMismatch on Glutathione S-Transferase T1 Increases the Risk of Graft-versus-Host Disease and Mortality after Allogeneic Stem Cell Transplantation
- 1 July 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46 (7) , 663-664
De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency
- 1 July 2014
- Published by Elsevier in Digestive and Liver Disease
- Vol. 46 (7) , 663-664
De novo autoimmune hepatitis after interferon treatment in a liver transplant recipient with common variable immunodeficiency
- 7 February 2014
- Published by SAGE Publications in Lupus
- Vol. 23 (4) , 353-359
Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus
Objective: The aim of this study was to investigate the pattern of microRNA (miRNA) expression in CD19+ and CD4+ cells from asymptomatic patients with systemic lupus erythematosus (SLE). Methods: A screening of the expression of 377 miRNAs was performed in human CD4+ and CD19+ cells isolated from the peripheral blood by using a TaqMan Human MicroRNA Array. Validation of differential expression pattern of those was performed using TaqMan assays in these cell populations obtained from a larger cohort of patients and controls. Results: According to the screening assays, three miRNAs were differentially expressed ( p value <0.1) in cell populations from both patients and controls: hsa-miR-143, hsa-miR-224 and hsa-miR-576-5p for CD4+ cells, and hsa-miR-10a, hsa-miR-31 and hsa-miR-345 for CD19+ cells. After validation, significant differences ( p value <0.05) were confirmed only for hsa-miR-143 and hsa-miR-224 in CD4+ cells and for hsa-miR-10a and hsa-miR-345 in CD19+ cells. In all cases, the miRNAs were over expressed in SLE patients compared with healthy donors. Conclusions: Our results support a different pattern of miRNA expression in SLE patients.
- 7 February 2014
- Published by SAGE Publications in Lupus
- Vol. 23 (4) , 353-359
Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus
Objective: The aim of this study was to investigate the pattern of microRNA (miRNA) expression in CD19+ and CD4+ cells from asymptomatic patients with systemic lupus erythematosus (SLE). Methods: A screening of the expression of 377 miRNAs was performed in human CD4+ and CD19+ cells isolated from the peripheral blood by using a TaqMan Human MicroRNA Array. Validation of differential expression pattern of those was performed using TaqMan assays in these cell populations obtained from a larger cohort of patients and controls. Results: According to the screening assays, three miRNAs were differentially expressed ( p value <0.1) in cell populations from both patients and controls: hsa-miR-143, hsa-miR-224 and hsa-miR-576-5p for CD4+ cells, and hsa-miR-10a, hsa-miR-31 and hsa-miR-345 for CD19+ cells. After validation, significant differences ( p value <0.05) were confirmed only for hsa-miR-143 and hsa-miR-224 in CD4+ cells and for hsa-miR-10a and hsa-miR-345 in CD19+ cells. In all cases, the miRNAs were over expressed in SLE patients compared with healthy donors. Conclusions: Our results support a different pattern of miRNA expression in SLE patients.
- 1 November 2013
- Published by Elsevier in Human Immunology
- Vol. 74 (11) , 1470-1473
Clinical relevance of GSTT1 mismatch in solid organ and hematopoietic stem cell transplantation
- 1 November 2013
- Published by Elsevier in Human Immunology
- Vol. 74 (11) , 1470-1473
Clinical relevance of GSTT1 mismatch in solid organ and hematopoietic stem cell transplantation
- Open Access
- 4 October 2013
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 15 (5) , R145
HLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
Introduction: According to genome wide association (GWA) studies as well as candidate gene approaches, Behçet’s disease (BD) is associated with human leukocyte antigen (HLA)-A and HLA-B gene regions. The HLA-B51 has been consistently associated with the disease, but the role of other HLA class I molecules remains controversial. Recently, variants in non-HLA genes have also been associated with BD. The aims of this study were to further investigate the influence of the HLA region in BD and to explore the relationship with non-HLA genes recently described to be associated in other populations. Methods: This study included 304 BD patients and 313 ethnically matched controls. HLA-A and HLA-B low resolution typing was carried out by PCR-SSOP Luminex. Eleven tag single nucleotide polymorphisms (SNPs) located outside of the HLA-region, previously described associated with the disease in GWA studies and having a minor allele frequency in Caucasians greater than 0.15 were genotyped using TaqMan assays. Phenotypic and genotypic frequencies were estimated by direct counting and distributions were compared using the χ2 test. Results: In addition to HLA-B*51, HLA-B*57 was found as a risk factor in BD, whereas, B*35 was found to be protective. Other HLA-A and B specificities were suggestive of association with the disease as risk (A*02 and A*24) or protective factors (A*03 and B*58). Regarding the non-HLA genes, the three SNPs located in IL23R and one of the SNPs in IL10 were found to be significantly associated with susceptibility to BD in our population. Conclusion: Different HLA specificities are associated with Behçet’s disease in addition to B*51. Other non-HLA genes, such as IL23R and IL-10, play a role in the susceptibility to the disease.
- 4 October 2013
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 15 (5) , R145
Open AccessHLA and non-HLA genes in Behçet’s disease: a multicentric study in the Spanish population
Introduction: According to genome wide association (GWA) studies as well as candidate gene approaches, Behçet’s disease (BD) is associated with human leukocyte antigen (HLA)-A and HLA-B gene regions. The HLA-B51 has been consistently associated with the disease, but the role of other HLA class I molecules remains controversial. Recently, variants in non-HLA genes have also been associated with BD. The aims of this study were to further investigate the influence of the HLA region in BD and to explore the relationship with non-HLA genes recently described to be associated in other populations. Methods: This study included 304 BD patients and 313 ethnically matched controls. HLA-A and HLA-B low resolution typing was carried out by PCR-SSOP Luminex. Eleven tag single nucleotide polymorphisms (SNPs) located outside of the HLA-region, previously described associated with the disease in GWA studies and having a minor allele frequency in Caucasians greater than 0.15 were genotyped using TaqMan assays. Phenotypic and genotypic frequencies were estimated by direct counting and distributions were compared using the χ2 test. Results: In addition to HLA-B*51, HLA-B*57 was found as a risk factor in BD, whereas, B*35 was found to be protective. Other HLA-A and B specificities were suggestive of association with the disease as risk (A*02 and A*24) or protective factors (A*03 and B*58). Regarding the non-HLA genes, the three SNPs located in IL23R and one of the SNPs in IL10 were found to be significantly associated with susceptibility to BD in our population. Conclusion: Different HLA specificities are associated with Behçet’s disease in addition to B*51. Other non-HLA genes, such as IL23R and IL-10, play a role in the susceptibility to the disease.
- 11 September 2013
- Published by Wiley in Liver International
- Vol. 34 (6) , e80-e88
Hepatitis C virus‐specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells
Background & Aims: Hepatitis C virus (HCV)‐RNA detection in peripheral blood mononuclear cells (PBMCs) after recovery from HCV infection, is a type of occult HCV infection although is unclear how the viral persistence in PBMCs affects HCV‐specific T‐cell responses. The aim of this study was to investigate if cellular immune responses are modified by HCV persistence in PBMCs.Methods: HCV‐specific CD4+ and CD8+ T‐cell responses against six HCV peptides, situated within the non‐structural (NS) proteins NS3, NS4b and NS5b, were measured by flow cytometry‐through intracellular detection of gamma interferon (IFN‐γ) or interleukin 4 (IL‐4) and CD69 expression‐ in 27 sustained virological responders (SVR): 13 with and 14 without occult HCV infection in PBMCs, detected by strand‐specific real‐time PCR. Ten healthy individuals and 14 chronically infected patients with viraemia, were included as controls.Results: SVR without occult infection showed a higher percentage of activated CD4+ cells against peptides belonging to NS3 (p124, p153) and NS5b (p257, p294), activated CD8+ cells against NS3 (p124, p153, p158) and NS5b‐p294, as well as an elevated percentage of CD4+ cells releasing IFN‐γ + IL‐4 against NS3‐p153, and by CD8+ cells against NS3 (p124, p153). SVR without occult infection showed a higher percentage of activation and release of IFN‐γ + IL‐4 by both cell subpopulations than the two group of controls, in contrast to SVR with occult infection.Conclusion: The lower HCV‐specific T‐cell response found in SVR with occult infection indicates that the immune response may be impaired when the virus persists in PBMCs.
- 11 September 2013
- Published by Wiley in Liver International
- Vol. 34 (6) , e80-e88
Hepatitis C virus‐specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells
Background & Aims: Hepatitis C virus (HCV)‐RNA detection in peripheral blood mononuclear cells (PBMCs) after recovery from HCV infection, is a type of occult HCV infection although is unclear how the viral persistence in PBMCs affects HCV‐specific T‐cell responses. The aim of this study was to investigate if cellular immune responses are modified by HCV persistence in PBMCs.Methods: HCV‐specific CD4+ and CD8+ T‐cell responses against six HCV peptides, situated within the non‐structural (NS) proteins NS3, NS4b and NS5b, were measured by flow cytometry‐through intracellular detection of gamma interferon (IFN‐γ) or interleukin 4 (IL‐4) and CD69 expression‐ in 27 sustained virological responders (SVR): 13 with and 14 without occult HCV infection in PBMCs, detected by strand‐specific real‐time PCR. Ten healthy individuals and 14 chronically infected patients with viraemia, were included as controls.Results: SVR without occult infection showed a higher percentage of activated CD4+ cells against peptides belonging to NS3 (p124, p153) and NS5b (p257, p294), activated CD8+ cells against NS3 (p124, p153, p158) and NS5b‐p294, as well as an elevated percentage of CD4+ cells releasing IFN‐γ + IL‐4 against NS3‐p153, and by CD8+ cells against NS3 (p124, p153). SVR without occult infection showed a higher percentage of activation and release of IFN‐γ + IL‐4 by both cell subpopulations than the two group of controls, in contrast to SVR with occult infection.Conclusion: The lower HCV‐specific T‐cell response found in SVR with occult infection indicates that the immune response may be impaired when the virus persists in PBMCs.
- 1 May 2013
- Published by Elsevier in Human Immunology
- Vol. 74 (5) , 545-549
Influence of donor specific HLA antibodies detected by Luminex in kidney graft survival: A multivariate analysis
- 1 May 2013
- Published by Elsevier in Human Immunology
- Vol. 74 (5) , 545-549
Influence of donor specific HLA antibodies detected by Luminex in kidney graft survival: A multivariate analysis
- Open Access
- 15 January 2013
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 15 (1) , R11
Association of the AIRE gene with susceptibility to rheumatoid arthritis in a European population: a case control study
Introduction: AIRE is a transcriptional regulator playing a functional role in thymocyte education and negative selection by controlling the expression of peripheral antigens in the thymus. Recently, the AIRE gene was identified as a genetic risk factor for rheumatoid arthritis (RA) in genome wide association (GWA) studies performed in the Japanese population. According to the available data this association is restricted to the Asian population. However, different facts could influence the lack of association in Caucasian populations. The aim of this study was to further investigate the possible role of the AIRE gene in susceptibility to RA in a Caucasian population. Methods: A total of 472 Spanish Caucasian RA patients and 475 ethnically matched controls were included in the study. Three single-nucleotide polymorphisms (SNPs) (rs2776377, rs878081 and rs1055311) with a minor allele frequency >0.05 in the Caucasian population which were not included in the high-throughput platforms used in the GWA studies performed in susceptibility to RA, and two SNPs (rs2075876 and rs1800520) associated with RA in the Japanese population, were selected and genotyped using TaqMan assays. Results: No significant differences in the distribution of the alleles of rs2776377, rs2075876, rs1055311 and rs1800520 SNPs between RA patients and controls were observed. Nevertheless, the frequency of the C allele of rs878081 was significantly higher among RA patients (80.5% vs. 74.6% in the control group, pc = 0.012, OR = 1.41, 95%CI 1.13-1.75). Regarding the distribution of the rs878081 genotypes, a higher frequency of CC homozygous individuals was found in the RA patient group (65.56% vs. 56.47% in the control group, pc = 0.013, OR = 1.47, 95%CI 1.12-1.93). The in silico analysis predicted lower affinity to the binding-site of a motif of the transcription NF-κB family and lower transcription levels of AIRE gene for the rs878081C risk variant Conclusions: Our findings suggest that the AIRE gene is associated with susceptibility to RA in the Spanish population. Probably, this association has not been detected in the European population in the GWA studies because the earliest high-throughput platforms did not include SNP suitable markers (e.g. rs878081).
- 15 January 2013
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 15 (1) , R11
Open AccessAssociation of the AIRE gene with susceptibility to rheumatoid arthritis in a European population: a case control study
Introduction: AIRE is a transcriptional regulator playing a functional role in thymocyte education and negative selection by controlling the expression of peripheral antigens in the thymus. Recently, the AIRE gene was identified as a genetic risk factor for rheumatoid arthritis (RA) in genome wide association (GWA) studies performed in the Japanese population. According to the available data this association is restricted to the Asian population. However, different facts could influence the lack of association in Caucasian populations. The aim of this study was to further investigate the possible role of the AIRE gene in susceptibility to RA in a Caucasian population. Methods: A total of 472 Spanish Caucasian RA patients and 475 ethnically matched controls were included in the study. Three single-nucleotide polymorphisms (SNPs) (rs2776377, rs878081 and rs1055311) with a minor allele frequency >0.05 in the Caucasian population which were not included in the high-throughput platforms used in the GWA studies performed in susceptibility to RA, and two SNPs (rs2075876 and rs1800520) associated with RA in the Japanese population, were selected and genotyped using TaqMan assays. Results: No significant differences in the distribution of the alleles of rs2776377, rs2075876, rs1055311 and rs1800520 SNPs between RA patients and controls were observed. Nevertheless, the frequency of the C allele of rs878081 was significantly higher among RA patients (80.5% vs. 74.6% in the control group, pc = 0.012, OR = 1.41, 95%CI 1.13-1.75). Regarding the distribution of the rs878081 genotypes, a higher frequency of CC homozygous individuals was found in the RA patient group (65.56% vs. 56.47% in the control group, pc = 0.013, OR = 1.47, 95%CI 1.12-1.93). The in silico analysis predicted lower affinity to the binding-site of a motif of the transcription NF-κB family and lower transcription levels of AIRE gene for the rs878081C risk variant Conclusions: Our findings suggest that the AIRE gene is associated with susceptibility to RA in the Spanish population. Probably, this association has not been detected in the European population in the GWA studies because the earliest high-throughput platforms did not include SNP suitable markers (e.g. rs878081).